Biogen CEO confirms he’s shopping for biotechs: ‘We will be doing deals’
SAN FRANCISCO — Biogen would like to make additional biotech acquisitions in 2025 beyond Friday’s offer to buy its financially troubled partner Sage Therapeutics, chief executive Chris Viehbacher told me Sunday.
“We will be doing deals — the size of those deals, I cannot say,” he said in an interview ahead of the J.P. Morgan Healthcare Conference.
Biogen offered to buy Sage, its marketing partner on Zurzuvae, a pill to treat postpartum depression, for $469 million — less than the $569 million in cash that Sage has on hand as of September. The lowball offer is unlikely to be accepted, but Sage also has little leverage after a series of clinical failures last year wiped out its research pipeline and decimated its stock price.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
Related
Rare Grocery-Anchored Deal: Park Ridge Shopping Center Sells For $17M
Ridgemont Shopping Center attracted significant interest, with more than 20 offers from investors, highlighting its prime locati
Gwyneth Paltrow enjoys shopping trip in California with husband Brad…
Have YOU got a story? Email tips@dailymail.comBy JO MACFARLANE Published: 22:00 GMT, 12 January 2025 | Updated: 22:10 GMT, 12 January 2025
Blazers ‘Not Actively’ Shopping Vet Big Man in Trade Talks:…
The Portland Trail Blazers are one of the teams that everyone is watching now that the trade deadline is approaching. Even though there is still a month left be
‘Makes me look thinner’ This cozy shawl is down to…
Tired of feeling frumpy in your oversized plush coat? You're not alone. If you're looking for something a bit more stylish, yet warm and cozy, take a look at th
